(Q40707885)
Statements
Carboplatin and alpha-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot study (English)
G Frasci
A Tortoriello
S Conforti
G Persico
P Mastrantonio
A Cardone